Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Ahead of the Bell: Nasdaq halts Optimer trading
Yahoo/AP
Tuesday, April 5, 2011 - 10:43am
tags:
Optimer, antibiotics, fidaxomicin
Neurocrine Tardive drug meets midstage study goals
Yahoo/AP
Tuesday, April 5, 2011 - 10:38am
tags:
Tardive, Neurocrine
Merck to acquire Inspire Pharma for $430 million
Reuters
Tuesday, April 5, 2011 - 10:28am
tags:
Inspire, Merck, M&A
J&J, Bayer’s Xarelto Curbs Clots, Raises Bleeding Risk in Clinical Study
Bloomberg
Tuesday, April 5, 2011 - 10:24am
tags:
JNJ, Bayer, Xarelto
Blockbuster antibodies face a unique set of challenges
Fierce Biotech
Tuesday, April 5, 2011 - 9:13am
tags:
monoclonal antibodies, antibodies
4 Biotech Companies That Could Be Buyout Targets
Seeking Alpha
Tuesday, April 5, 2011 - 9:07am
tags:
Athersys, Biomarin, Celgene, Amgen
Gilead Sciences Raises Price Of Top Selling Products
Morningstar
Tuesday, April 5, 2011 - 8:42am
tags:
Gilead Sciences, drug pricing, HIV
Optimer Pharma: FDA Panel Live Blog
TheStreet.com
Tuesday, April 5, 2011 - 8:36am
tags:
FDA, advisory panels, Optimer, antibiotics, fidaxomicin
Valeant Pressures Cephalon for Faster Decision, Goes Hostile With $5.7B Bid
Seeking Alpha
Tuesday, April 5, 2011 - 8:34am
tags:
hostile bid, Cephalon, Valeant Pharmaceuticals
What Pfizer left behind with Capsugel
CNN/Fortune
Tuesday, April 5, 2011 - 8:33am
tags:
Pfizer, Capsugel
Finding the source of J&J's river of woe
Fierce Pharma
Monday, April 4, 2011 - 11:07pm
tags:
JNJ, recalls
The 15 Most-Watched Biotech Stocks
Motley Fool
Monday, April 4, 2011 - 11:06pm
tags:
Gilead Sciences, Exelixis, Amgen, Dendreon, Immunogen, Maxygen, MannKind, PDL Biopharma, Celgene, Geron, Vertex Pharmaceuticals, Arena Pharmaceuticals, Human Genome Sciences, Orexigen, Biogen Idec
BioMarin won't seek control of drug as Sanofi-Genzyme deal closes
Bizjournals.com
Monday, April 4, 2011 - 11:00pm
tags:
Biomarin, Sanofi, Genzyme, Aldurazyme
Biotech Busts And Breakthroughs For March
Forbes
Monday, April 4, 2011 - 10:58pm
tags:
Pharmasset, KV Pharmaceutical, Ista, Pain Therapeutics, Cytori
Cubist Surges After Teva Licenses Cubicin Antibiotic in Patent Settleme
Bloomberg
Monday, April 4, 2011 - 10:54pm
tags:
antibiotics, Teva Pharmaceuticals, Cubicin, Cubist Pharmaceuticals
Biotech IPOs Continue Bleeding Money
WSJ Online
Monday, April 4, 2011 - 10:52pm
tags:
IPOs, Tranzyme
Impax files for approval of generic heartburn drug
Yahoo/AP
Monday, April 4, 2011 - 10:50pm
tags:
generics, heartburn, Impax, Takeda, Dexilant
Lilly's Axiron Launched in the U.S.
Yahoo/Zacks.com
Monday, April 4, 2011 - 10:49pm
tags:
Eli Lilly, Axiron, testosterone
Novartis chief continues cost-cutting drive
Fierce Pharma
Monday, April 4, 2011 - 11:40am
tags:
Novartis, Joe Jimenez, Pharma CEOs, layoffs
Has The Pfizer Break Up Begun?
Pharmalot
Monday, April 4, 2011 - 11:39am
tags:
Pfizer, Capsugel

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.